eMedicine Specialties > Pediatrics: General Medicine > Parasitology

Ascariasis

Author: William H Shoff, MD, DTM&H, Director, PENN Travel Medicine, Associate Professor, Department of Emergency Medicine, Hospital of the University of Pennsylvania
Coauthor(s): Suzanne Moore Shepherd, MD, MS, DTM&H, FACEP, FAAEM, Associate Professor, Department of Emergency Medicine, Hospital of the University of Pennsylvania; Director of Education and Research, PENN Travel Medicine; Michael E Greenberg, MD, MPH, Clinical Instructor, Department of Pediatrics, University of California at San Francisco
Contributor Information and Disclosures

Updated: Jun 11, 2008

Introduction

Background

Ascaris lumbricoides, which causes ascariasis, is the largest of the round worms (nematodes), with females measuring 30 cm x 0.5 cm. It is present in the GI tract (small intestine) of 1.2–1.5 billion individuals in tropical and subtropical areas, making it the most common nematode infection in the world. The number of cases in the United States is estimated to be 4 million, with transmission occurring in the Gulf States and southern New Mexico and southern Arizona.

The parasite is acquired through ingestion of embryonated eggs. Ascariasis is usually asymptomatic but can be complicated by several conditions, including appendicitis, bowel perforation, cholecystitis, intestinal obstruction (large numbers), malabsorption (eg, lactose, nitrogen, vitamin A), and pancreatitis. The mortality rate is 5% if complications occur. When the parasite migrates through the lung early in its parasitic cycle, it can also cause pneumonitis. The mainstays of chemotherapy include albendazole, mebendazole, and pyrantel pantoate (for alternatives, see Medication).

A lumbricoides is one of the soil-transmitted helminths (STH), a group that includes 16 worms. Many individuals are infected with 2-3 of the 3 major parasites (ie, A lumbricoides, Trichuris trichiura, and hookworm).

Table 1. Major Soil-Transmitted Helminths1,2

Open table in new window

Table
Parasite*DiseasePrevalence
A lumbricoidesCommon roundworm infection, ascariasis800 million to 1.4 billion
T trichiuraWhipworm infection, trichuriasis600 million to 1 billion
Necator americanus and
Ancylostoma duodenale
Hookworm infection580 million to 1.2 billion
Strongyloides stercoralisThreadworm infection, strongyloidiasis 30-300 million
Enterobius vermicularisPinworm infection4-28% of children
Toxocara canis and
Toxocara cati
Visceral larva migrans and ocular larva migrans2-80% of children
Parasite*DiseasePrevalence
A lumbricoidesCommon roundworm infection, ascariasis800 million to 1.4 billion
T trichiuraWhipworm infection, trichuriasis600 million to 1 billion
Necator americanus and
Ancylostoma duodenale
Hookworm infection580 million to 1.2 billion
Strongyloides stercoralisThreadworm infection, strongyloidiasis 30-300 million
Enterobius vermicularisPinworm infection4-28% of children
Toxocara canis and
Toxocara cati
Visceral larva migrans and ocular larva migrans2-80% of children

*All major parasites are found in tropical, subtropical, and temperate climates.
 
Table 2. Minor Soil-Transmitted Helminths1,2

Open table in new window

Table
Minor ParasiteDiseaseDistribution
Ancylostoma brazilienseCutaneous larva migransCostal regions worldwide
Uncinaria stenocephalaCutaneous larva migransCostal regions worldwide
Ancyclostoma caniumEosinophilic enteritisAustralia
Ancylostoma ceylanicumHookworm infectionAsia
Oesophagostomum bifurcumNodular worm infectionNorth America
Strongyloides fuelleborniSwollen belly syndromeWest Africa
Ternidens diminutusFalse hookworm infectionSouthern Africa
Minor ParasiteDiseaseDistribution
Ancylostoma brazilienseCutaneous larva migransCostal regions worldwide
Uncinaria stenocephalaCutaneous larva migransCostal regions worldwide
Ancyclostoma caniumEosinophilic enteritisAustralia
Ancylostoma ceylanicumHookworm infectionAsia
Oesophagostomum bifurcumNodular worm infectionNorth America
Strongyloides fuelleborniSwollen belly syndromeWest Africa
Ternidens diminutusFalse hookworm infectionSouthern Africa

By chronically infecting school-aged children, usually in developing countries, these parasites significantly contribute to cognitive deficits, growth stunting, mental retardation, and malnutrition. The 3 most important infections are ascariasis (A lumbricoides) , trichuriasis (T trichiura), and hookworm (N americanus and  A duodenale); often, all 3 parasites can be found in a single individual. The combined disease burden of the STHs is estimated to be equivalent to malaria or tuberculosis.

Although A lumbricoides has been present in humans for many thousands of years, science only began to elucidate its biology in the 17th century, and effective chemotherapy was only developed in the late 20th century. The earliest recovered eggs are from the 30,000-year-old Upper-Paleolithic site of Arcy-sur-Cure in Yonne, France. Infertile eggs have been reported in coprolites dating to 2277 BCE from an archeological site at Los Gavilanes, Peru. Desiccated human feces from Big Bone Cave, Tennessee dating to approximately 2177 BCE contained A lumbricoides. In the Nubian aspect of the Nile River, eggs have been recovered inside a mummy dating to 2050-1750 BCE.

In 1683, Tyson discussed " Lumbricus teres …observations on the Round Worm bred in human bodies….that common Round Worm which children u[s]ually are troubled with." In 1758, Linnaeus proposed the name Ascaris lumbricoides. In 1856, Ransom reported that finding eggs in fecal samples was a reliable means of diagnosis. In 1862, Davaine concluded that ingested embryonated eggs produced ascariasis and that the infected host would produce eggs in feces that could pass the infection to another host. In the 1980s, several reviews noted the public health impact of STH infection and suggested control strategies using antihelminthic drugs, some of which were introduced in the 1960s (eg, pyrantel pantoate) and 1970s (eg, mebendazole).

The genus Ascaris is composed of 17 species. A lumbricoides has a high host specificity for humans and, rarely, for pigs. It has been reported in other hosts, including cats, chimpanzees, domestic dogs, gibbons, gorillas, guinea-pigs, lambs, macaques, monkeys, rabbits, rats, and squirrels; however, it has not been demonstrated to achieve sexual maturity or to produce fertile eggs in these hosts.

Ascaris suum has a high host specificity for domestic pigs and, rarely, humans. It has been reported in other hosts, including domestic cattle, gorillas, goats, lambs, monkeys, mice, rabbits, and rats. As with A lumbricoides, A suum has not been demonstrated to achieve sexual maturity or to produce fertile eggs in these hosts. The other 15 species of Ascaris are not reported in humans. Therefore, A lumbricoides does not have an animal reservoir.

Pathophysiology

Species in the genus Ascaris are transmitted via the fecal-oral route, primarily from ingestion of agricultural products or food contaminated with parasite eggs.

Life cycle

Life cycle data come from investigations of A suum in pigs and A lumbricoides in mice. Little is known about the interaction of A lumbricoides larvae and humans.

Humans ingest A lumbricoides eggs, which contain stage 2 larvae and measure 50-70 µm x 40-50 µm. The eggs hatch in the jejunum and release the stage 2 larvae. They then penetrate the small intestinal wall (some evidence suggests the large intestine), enter the portal venous circulation, and migrates to the liver over 2-8 days. According to data from mice, they measure 258 µm x 14 µm at this stage. The larvae then migrate via the venous circulation to the pulmonary circulation and to the lungs. Here, the larvae measure 564 µm x 28 µm. They then break into the alveolar spaces, molt to the stage 3 larvae, grow to 1,700–2,000 µm, and molt to stage 4 larva, all over 4-14 days. They then ascend the trachea, are swallowed, return to the small intestine (usually intestine), molt for the final time, and develop into mature adults, all over 14-20 days. The total elapsed time in humans from the time of ingestion todevelopment of mature adults is 18-42 days.

The size range of the mature female is 20-40 cm x 0.5–0.6 cm; the mature male is somewhat smaller at 12-25 cm x 0.3-0.4 cm. The Ascaris genus contains the largest of the nematode parasites; the migration through the tissues appears to confer this size advantage. In general, alimentary tract nematodes (700 species) that migrate through tissues grow faster.

Females produce approximately 200,000 eggs per day (134,462-358,750), although this number fluctuates. In the presence of a male, the eggs are fertilized by copulation. Female-only infections produce nonfertilized eggs that cannot become infective. Male-only infections produce no eggs. The prepatent period (time from ingestion of the egg to detection of the eggs in feces) is 67-76 days (67 d in children <4 y). A suum infections in humans have a similar life cycle, with a prepatent period of 24-29 days.

The life span of A lumbricoides is 1-2 years. Eggs, fertilized and unfertilized, are released to the environment via feces. Unfertilized eggs do not become infective. Fertilized eggs cannot infect until they embryonate outside the human body under proper conditions. Fertile eggs have 4 layers. The outer layer, which is not always present, consists of an extruded, sticky mucopolysaccharide from the parent female worm. This provides adhesiveness thought to be advantageous, allowing the eggs to stick to many types of surfaces. The other 3 layers are secreted by the embryo and include an outer thin proteinaceous membrane, a middle protein and chitin layer that provides structural strength, and the inner ascaricide layer, which consists of protein (25%) and unsaponifiable lipid (75%). This inner ascaroside layer is selectively permeable and is important for the survival of the egg in various conditions.

To become infective, eggs must complete embryonization while in the soil. The zygote develops into a stage 1 larva and molts to a stage 2 larva within the egg shell. This occurs over 10-14 days at 28-32°C (82.4-89.6°F) and over 45-55 days at 16-18°C (60.8-64.4°F). Several factors favor survival of the egg, including the following:

  • Amount of moisture in the soil (ie, clay soil vs sandy soil)
  • Protection from direct sunlight (quickly kills eggs)
  • Temperatures of 5-34°C (41-93.2°F): A temperatures of 40°C (104°F) is lethal. A temperature of 38°C (68.4°F) is lethal after 8 days.
  • Soil humidity of more than 4%: The length of survival is 4.5 hours or less with soil humidity of less than 4%, varies at 4-50% soil humidity, and is best at more than 50% soil humidity
  • Formation of stage 2 larvae in the egg

Freezing at –15°C to –12°C (0.4-5°F) for 90 days kills all eggs except those at the single blastomere stage. Depth in the soil is another major influence. Experimentally, under similar climatic conditions, eggs survive 21–29 days on the surface, 1.5 years or less at a depth of 10-20 cm, and 2.5 years or less at a depth of 40-60 cm. Eggs and infective larva can survive over winter to infect in warmer weather. Under experimental conditions, eggs have survived for 6-14 years in the soil. However, in general, eggs are expected to survive 28-84 days. In areas of endemicity, particularly where night soil (human feces) or untreated wastewater is used as fertilizer, the egg concentration is 100 eggs per gram of soil. Eggs can be spread through the soil by earthworms, insects (eg, termites), and other burrowing animals. Egg-contaminated dust can be spread by wind and can lead to human infection via inhalation and swallowing.

In endemic areas eggs contaminate numerous domestic sites, including the following:2

  • Chopping boards
  • Coins
  • Door handles
  • Dust
  • Fingers
  • Fingernail dirt
  • Fruit
  • Furniture
  • Insects
  • Nasal discharge
  • Paper money
  • Pickles
  • Public baths
  • School rooms
  • Underclothes
  • Vegetables
  • Wash basins

The average number of female offspring that attain reproductive capacity (reproductive number) produced by one adult female A lumbricoides worm is 1-6.

A lumbricoides and A suum

Evidence suggests that these parasites are separate species, although they are closely related. A lumbricoides infects humans almost exclusively and rarely infects pigs. A suum infects pigs almost exclusively and rarely infects humans. A lumbricoides has occasionally been reported in other animals, such as bears and primates, and A suum has occasionally been reported in cattle or sheep.

Morphologically, they are essentially indistinguishable; however, several reports cite differences in the denticles as a distinguishing characteristic. The morphology of the sex chromosomes exhibits differences, suggesting that the species are different. Species differences in the internal transcribed sequences of the ribosomal DNA have been reported, allowing differentiation. Protein profiles using 2-dimensional electrophoresis reveal reproducible differences. The current consensus is that these are, in fact, different species; however, they are closely related enough biologically that data on the life cycle and pathology of A suum have been extrapolated to humans.

Pathophysiological mechanism

Adult worms move throughout the GI tract and move in and out of orifices (eg, biliary tract, pancreas, appendix, diverticula, Meckel diverticulum) and may become incarcerated, leading to obstructive pathology. The worms may die, leading to inflammation, necrosis, infection, and abscess formation. If they migrate through an existing perforation in the bowel wall secondary to tuberculosis or typhoid, they can cause a granulomatous peritonitis. Larvae during migration may be deposited in the brain, spinal cord, kidney, or other organs, leading to granuloma formation, inflammation, or infection. They may become entwined in a bolus and obstruct the small bowel; this is most common in the terminal ileum, although other, more proximal, sites have been rarely reported.

This condition may be precipitated by the administration of an antihelminthic drug (see Medication). Eggs may be deposited in the liver or biliary tract. If they gain entry to the blood, they are deposited in extraneous sites, leading to local reactions.

Only a small percentage of Ascaris infections produce serious, acute pathology; however, because about one quarter of the human population is infected, the number of cases is significant.

Immunology

Humans make antibodies in response to Ascaris antigens and infection; immunoglobulin (Ig) E is predominant.3 The response is heterogeneous and is believed to confer some immunity. Evidence also suggests that whatever immunoprotection is conferred is not immunoglobulin-based.

An association has been reported between egg excretion in children and increased prevalence of allergic disorders (eg, asthma) compared with children who do not excrete eggs. Because ascariasis and other helminthic infections are long-lived without producing consistently serious symptoms, a significant immunomodulatory relationship must occur between the infection and the human host, the details of which have not been fully clarified. Future research may lead to the development of vaccines and other interventions that will permit better control and treatment of this pervasive parasitic disease.

Frequency

United States

In the United States, more than 4 million individuals are believed to be infected with Ascaris species. Most infected persons are immigrants from developing countries, although the species are endemic in the southeastern United States in rural, low-income families.

International

Worldwide, more than 1.4 billion people are infected with ascariasis. The distribution of cases is as follows:

  • South America, Central America, and the Caribbean - 8.3%
  • Africa and the Middle East - 16.7%
  • Asia and the Oceania region - 75%

Ascariasis is present in at least 150 of the 218 countries in the world. Prevalence estimates widely vary among countries and within communities inside these countries.

Mortality/Morbidity

Annual mortality estimates range from 10,000-200,000. Currently, the rate is believed to be 10,000 deaths per year based on more detailed calculations.

Morbidity is proportional to the worm burden. A large majority of cases are asymptomatic. Intestinal obstruction, the most common complication of ascariasis, has been reported with as few as 4 worms. The average worm burden in numerous nonfatal case reports was 59 worms (range, 4-990); in fatal cases, the average worm burden was 659 (range, 23-1978).

Based on numerous reports in the literature, a rough estimate of the occurrence of complications is as follows:2

  • Intestinal obstruction - 63% 
  • Bile duct obstruction - 23%
  • Perforation, peritonitis, or both - 3.2%
  • Volvulus - 2.7%
  • Hepatitic abscess - 2.1%
  • Appendicitis - 2.1%
  • Pancreatitis - 1%
  • Cerebral encephalitis - 1%
  • Intussusception - 0.5%
Other sites of pathology (<0.5%) include Meckel diverticulum, the gallbladder, ears, eyes, nose, lungs, kidneys, vagina, urethra, heart, placenta, spleen, thoracic cavity, and umbilicus. In endemic regions, ascariasis is a significant part of the differential diagnosis for intestinal obstruction, appendicitis, biliary tract disease, pancreatitis, intussusception, and volvulus.

Public health issues

A lumbricoides and other STHs have been shown to play a significant role in childhood malnutrition, which leads to growth retardation, cognitive impairment, and poor academic performance, resulting in a poorer quality of life and less ability to contribute to society. For the 3 major STHs, the disability-adjusted life years lost is 39 million years. Ascariasis accounts for 10.5 million years, hookworm infection accounts for 22.1 million years, and trichuriasis accounts for 6.4 million years. In comparison, malaria accounts for 35.7 million years.

Race

No racial predilection is recognized.

Sex

Hepatobiliary and pancreatic ascariasis (HPA) occurs with a greater frequency in women than men (76% in one series).4 In the same series, biliary surgery was more frequent in women (77%) and was an important risk factor for HPA. No other sex association is reported.

Age

Intestinal obstruction predominates in young children (85% of cases occur in children aged 1-5 y) but can occur at any age.

HPA is more common in adults than in children. In one large series of 500 patients, the age range was 4-70 years (median, 35 y).5

Clinical

History

Most individuals are asymptomatic, even in communities where the prevalence is high. The most common manifestation is asymptomatic passage of an adult worm via the rectum, particularly in children in endemic areas. Rarely, an adult in a nonendemic area who is asymptomatic passes a worm via the rectum and may not be able to recount any significant exposure history. Less frequently, a worm migrates to the oropharynx and is coughed out. Ascaris eggs are often found in the stools of asymptomatic individuals in endemic areas. Some individuals with known significant worm burdens report anorexia, abdominal discomfort, and diarrhea; however, these symptoms cannot be directly attributed to ascariasis.

Pulmonary ascariasis

Symptoms develop 1-2 weeks after infection; they vary from none to life-threatening (rare), depending on sensitization or considerable migrating worm burden. Symptoms include chest pain (burning, aggravated by cough), cough (dry), dyspnea, fever, sputum (may be blood-tinged), and wheezing.

A massive infestation can lead to Löeffler syndrome (ie, transient eosinophilia, transient lung infiltrates); ascariasis remains the most common cause of this syndrome worldwide. In areas of continuous transmission, pulmonary symptoms tend to be less evident. Urticaria is present in 15% of patients and usually develops in the first 4-5 days of illness. Symptoms last 5-10 days but have been reported to last weeks in severe cases. 

Intestinal obstruction

Partial or complete obstruction secondary to an entangled worm bolus can occur at any age; however, 85% of cases occur in children aged 1-5 years and most occur at terminal ileum, although they have been rarely reported in the duodenum. The worm bolus may also cause intussusception or volvulus. Severe, sharp, colicky abdominal pain with associated vomiting predominates. The vomit may contain worms. Other common symptoms include fever and diarrhea. Depending on the duration of symptoms and the presence of comorbid conditions (eg, malnutrition), the patient may present with or progress rapidly to sepsis, sepsis syndrome, and septic shock.

Complete obstruction may begin subsequent to the administration of an antihelminthic, particularly in the setting of acute abdominal pain or partial bowel obstruction. Specific concern surrounds the administration of pyrantel pamoate, which causes a spastic paralysis of the worms and accentuates the potential for an obstructive bolus. Complete obstruction has also been reported with piperazine (flaccid paralysis of worms) and mebendazole (single large dose).

In endemic countries, ascariasis accounts for 5-35% of intestinal obstruction cases, particularly in children.

Hepatobiliary and pancreatic ascariasis and other GI diseases

Migrating adult worms (most common), worm fragments, or eggs can cause acalculous cholecystitis, ascending cholangitis, appendicitis, biliary colic, gastric hemorrhage, granulomatous peritonitis, liver abscess, Meckel diverticulum inflammation, obstructive jaundice, pancreatitis, and peritonitis and/or peritoneal granulomatosis (ie, ductal and/or intestinal perforation or migration through perforation secondary to typhoid or tuberculosis). Imaging with CT scanning and ultrasonography reveals the etiology in many cases. The etiology may not be apparent until endoscopic retrograde cholangiopancreatography (ERCP) or surgery is performed.

Extra-GI conditions

Worms may migrate to the upper respiratory tract (ie, throat, nose, lacrimal ducts, and inner ear); to the vagina; and to the kidney, ureter, and bladder (via the vagina).

Experimental studies report that the migrating larvae can enter many tissues, including the brain, kidney, and lymph nodes, but cannot survive. Several case reports have suggested encephalopathy secondary to Ascaris larvae.

Physical

Pulmonary ascariasis

In most cases, the lungs is clear or wheezing may be observed. In more severe cases, including ascaris pneumonia, a fever (£ 102ºF), rales, and wheezing may be observed. Dullness to percussion and bronchial breathing are rare, even in severe cases. Signs may persist for several days.

Intestinal obstruction or partial obstruction

The patient appears ill, often with abnormal vital signs (eg, tachycardia, fever) and may be actively vomiting and reporting severe abdominal pain. The abdomen is moderately-to-severely tender in a diffuse or localized pattern, usually on the right side. A palpable mass (worm bolus) may be observed. Assess for increasing pain, tachycardia, tachypnea, fever, abdominal tenderness, and vomiting, all of which may indicate progression of the obstruction, the development of sepsis, or perforation.

Hepatobiliary disease

Upon presentation, the patient may appear ill, may have abnormal vital signs (eg, tachycardia, tachypnea, fever), and may be actively vomiting. These patients usually report abdominal pain (mild, moderate, or severe). Depending on the pathology, the symptoms may rapidly progress rapidly over hours, as follows:

  • Biliary colic: Fever and jaundice are often absent; the worms are usually in the ampullary orifice, and removal results in rapid improvement.
  • Acalculous cholecystitis: Pain and tenderness in right upper quadrant are reported. Jaundice may or may not be present. The pain often radiates to the back on the right (see Cholecystitis).
  • Ascending cholangitis: The patient is usually critically ill with fever, tachycardia, tachypnea, jaundice, severe pain, and severe right upper quadrant or diffuse abdominal tenderness. The liver is tender and enlarged.
  • Pancreatitis: Moderate or severe pain and tenderness in the epigastrium and the left upper quadrant is reported, along with associated vomiting of varying intensity. The pain often radiates to the back on the left (see Pancreatitis and Pancreatic Pseudocyst).
  • Hepatic abscess: Severe pain and tenderness is reported in the right upper quadrant. The liver is tender and enlarged.

Causes

Ascariasis is caused by ingestion of an embryonated A lumbricoides egg or embryonated A suum egg (see Pathophysiology). Whether A suum and A lumbricoides are separate species remains controversial; however, evidence suggests that they may be distinct entities.

More on Ascariasis

Overview: Ascariasis
Differential Diagnoses & Workup: Ascariasis
Treatment & Medication: Ascariasis
Follow-up: Ascariasis
Multimedia: Ascariasis
References

References

  1. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. May 6 2006;367(9521):1521-32. [Medline].

  2. Crompton DW. Ascaris and ascariasis. Adv Parasitol. 2001;48:285-375. [Medline].

  3. Lynch NR, Hagel IA, Palenque ME, Di Prisco MC, et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol. Feb 1998;101(2 Pt 1):217-21. [Medline].

  4. Sandouk F, Haffar S, Zada MM, Graham DY, et al. Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol. Dec 1997;92(12):2264-7. [Medline].

  5. Khuroo MS, Zargar SA, Mahajan R. Hepatobiliary and pancreatic ascariasis in India. Lancet. Jun 23 1990;335(8704):1503-6. [Medline].

  6. Sherman SC, Weber JM. The CT diagnosis of Ascariasis. J Emerg Med. May 2005;28(4):471-2. [Medline].

  7. Arya PK, Kukreti R, Arya M, Gupta SN. Magnetic resonace appearance of gall bladder ascariasis. Indian J Med Sci. May 2005;59(5):208-10. [Medline].

  8. World Health Organization. Report of the third global meeting on the partners for parasite control: Deworming for health and develpment. Geneva: WHO; November 2004. [Full Text].

  9. World Health Organization. Report of the WHO informal consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months. Geneva: WHO; April 2002. [Full Text].

  10. Albonico M, Stoltzfus RJ, Savioli L. A controlled evaluation of two school-based anthelminthic chemotherapy regimens on intensity of intestinal helminth infections. Int J Epidemiol. Jun 1999;28(3):591-6. [Medline].

  11. Fallah M, Mirarab A, Jamalian F. Evaluation of two years of mass chemotherapy against ascariasis in Hamadan, Islamic Republic of Iran. Bull World Health Organ. 2002;80(5):399-402. [Medline].

  12. Abebe W, Tsuji N, Kasuga-Aoki H. Species-specific proteins identified in Ascaris lumbricoides and Ascaris suum using two-dimensional electrophoresis. Parasitol Res. Sep 2002;88(9):868-71. [Medline].

  13. Akgun Y. Intestinal obstruction caused by Ascaris lumbricoides. Dis Colon Rectum. Oct 1996;39(10):1159-63. [Medline].

  14. American Academy of Pediatrics. Ascaris lumbricoides infections. In: Peter G, ed. Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: AAP; 1997:142-3.

  15. Ash LR. Ascaris lumbricoides?. South Med J. Jan 2003;96(1):101-2. [Medline].

  16. Bapat SS, Pulikot AM. Hepato-cerebral complications in ascariasis. Indian Pediatr. Apr 2001;38(4):431-2. [Medline].

  17. Beckingham IJ, Cullis SN, Krige JE. Management of hepatobiliary and pancreatic Ascaris infestation in adults after failed medical treatment. Br J Surg. Jul 1998;85(7):907-10. [Medline].

  18. Beitia AO, Haller JO, Kantor A. CT findings in pediatric gastrointestinal ascariasis. Comput Med Imaging Graph. Jan-Feb 1997;21(1):47-9. [Medline].

  19. Bennett A, Guyatt H. Reducing intestinal nematode infection: efficacy of albendazole and mebendazole. Parasitol Today. Feb 2000;16(2):71-4. [Medline].

  20. Brooker S, Clements AC, Bundy DA. Global epidemiology, ecology and control of soil-transmitted helminth infections. Adv Parasitol. 2006;62:221-61. [Medline].

  21. Bude RO, Bowerman RA. Case 20: Biliary ascariasis. Radiology. Mar 2000;214(3):844-7. [Medline].

  22. Carneiro FF, Cifuentes E, Tellez-Rojo MM, Romieu I. The risk of Ascaris lumbricoides infection in children as an environmental health indicator to guide preventive activities in Caparao and Alto Caparao, Brazil. Bull World Health Organ. 2002;80(1):40-6. [Medline].

  23. Cooper PJ, Chico M, Sandoval C, Espinel I, Guevara A, Levine MM. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun. Mar 2001;69(3):1574-80. [Medline].

  24. Crompton DWT, Nesheim MC, Pawlowski ZS. Ascariasis and Its Prevention and Control. London, England: Taylor & Francis; 1989.

  25. de Silva NR, Brooker S, Hotez PJ. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. Dec 2003;19(12):547-51. [Medline].

  26. de Silva NR, Chan MS, Bundy DA. Morbidity and mortality due to ascariasis: re-estimation and sensitivity analysis of global numbers at risk. Trop Med Int Health. Jun 1997;2(6):519-28. [Medline].

  27. Gelpi AP, Mustafa A. Ascaris pneumonia. Am J Med. Mar 1968;44(3):377-89. [Medline].

  28. Gelpi AP, Mustafa A. Seasonal pneumonitis with eosinophilia. A study of larval ascariasis in Saudi Arabs. Am J Trop Med Hyg. Sep 1967;16(5):646-57. [Medline].

  29. Hui JY, Woo PC, Kan PS, Tang AP. A woman with ascites and abdominal masses. Lancet. Feb 12 2000;355(9203):546. [Medline].

  30. Inatomi Y, Murakami T, Tokunaga M, Ishiwata K, Nawa Y, Uchino M. Encephalopathy caused by visceral larva migrans due to Ascaris suum. J Neurol Sci. Apr 1 1999;164(2):195-9. [Medline].

  31. Ishiwata K, Shinohara A, Yagi K. Identification of tissue-embedded ascarid larvae by ribosomal DNA sequencing. Parasitol Res. Jan 2004;92(1):50-2. [Medline].

  32. Jones JL, Schulkin J, Maguire JH. Therapy for common parasitic diseases in pregnancy in the United States: a review and a survey of obstetrician/gynecologists' level of knowledge about these diseases. Obstet Gynecol Surv. Jun 2005;60(6):386-93. [Medline].

  33. Khuroo MS. Ascariasis. Gastroenterol Clin North Am. Sep 1996;25(3):553-77. [Medline].

  34. Larrubia JR, Ladero JM, Mendoza JL, Morillas JD, Diaz-Rubio M. The role of sonography in the early diagnosis of biliopancreatic Ascaris infestation. J Clin Gastroenterol. Jan 1996;22(1):48-50. [Medline].

  35. Loreille O, Bouchet F. Evolution of ascariasis in humans and pigs: a multi-disciplinary approach. Mem Inst Oswaldo Cruz. 2003;98 Suppl 1:39-46. [Medline].

  36. Mao XQ, Sun DJ, Miyoshi A, Feng Z, Handzel ZT, Hopkin JM. The link between helminthic infection and atopy. Parasitol Today. May 2000;16(5):186-8. [Medline].

  37. Norhayati M, Oothuman P, Azizi O, Fatmah MS. Efficacy of single dose albendazole on the prevalence and intensity of infection of soil-transmitted helminths in Orang Asli children in Malaysia. Southeast Asian J Trop Med Public Health. Sep 1997;28(3):563-9. [Medline].

  38. O'Lorcain P, Holland CV. The public health importance of Ascaris lumbricoides. Parasitology. 2000;121 Suppl:S51-71. [Medline].

  39. Ochoa B. Surgical complications of ascariasis. World J Surg. Mar-Apr 1991;15(2):222-7. [Medline].

  40. Reeder MM. The radiological and ultrasound evaluation of ascariasis of the gastrointestinal, biliary, and respiratory tracts. Semin Roentgenol. Jan 1998;33(1):57-78. [Medline].

  41. Rodriguez EJ, Gama MA, Ornstein SM, Anderson WD. Ascariasis causing small bowel volvulus. Radiographics. Sep-Oct 2003;23(5):1291-3. [Medline].

  42. Salman AB. Management of intestinal obstruction caused by ascariasis. J Pediatr Surg. Apr 1997;32(4):585-7. [Medline].

  43. Sandouk F, Anand BS, Graham DY. The whirlpool jet technique for removal of pancreatic duct ascaris. Gastrointest Endosc. Aug 1997;46(2):180-2. [Medline].

  44. Sarinas PS, Chitkara RK. Ascariasis and hookworm. Semin Respir Infect. Jun 1997;12(2):130-7. [Medline].

  45. Schulman A. Ultrasound appearances of intra- and extrahepatic biliary ascariasis. Abdom Imaging. Jan-Feb 1998;23(1):60-6. [Medline].

  46. Selimoglu MA, Ozturk CF, Ertekin V. A rare manifestation of ascariasis: encephalopathy. J Emerg Med. Jan 2005;28(1):87-8. [Medline].

  47. St Georgiev V. Pharmacotherapy of ascariasis. Expert Opin Pharmacother. Feb 2001;2(2):223-39. [Medline].

  48. Stephenson LS, Latham MC, Ottesen EA. Malnutrition and parasitic helminth infections. Parasitology. 2000;121 Suppl:S23-38. [Medline].

  49. Tondon A, Choudhury SP, Sharma D. Hypertonic saline enema in gastrointestinal ascariasis. Indian J Pediatr. Sep-Oct 1999;66(5):675-80. [Medline].

  50. van Riet E, Wuhrer M, Wahyuni S, Retra K, Deelder AM, Tielens AG. Antibody responses to Ascaris-derived proteins and glycolipids: the role of phosphorylcholine. Parasite Immunol. Aug 2006;28(8):363-71. [Medline].

  51. Villamizar E, Mendez M, Bonilla E, et al. Ascaris lumbricoides infestation as a cause of intestinal obstruction in children: Experience with 87 cases. J Pediatr Surg. Jan 1996;31(1):201-4; discussion 204-5. [Medline].

  52. World Health Organization. Control of Ascariasis. 1967. WHO technical report series. [Full Text].

  53. World Health Organization. Prevention and control of schistosomiasis and soil-transmitted helminths. WHO; 2002. WHO technical report series. [Full Text].

  54. Zargar SA, Khuroo MS. Management of biliary ascariasis in children. Indian J Gastroenterol. Oct 1990;9(4):321. [Medline].

Further Reading

Keywords

ascariasis, Ascaris lumbricoides, Ascaris species, roundworm, common roundworm infection, parasite, nematodes, helminthic infection, Ascaris larvae, Ascaris species infection, intestinal obstruction, IO, Loeffler pneumonitis, Löeffler pneumonitis, appendicitis, bowel perforation, cholecystitis, whipworm, trichuriasis, Trichuris trichiura, Necator americanus, Ancylostoma duodenale, Strongyloides stercoralis, Enterobius vermicularis, Toxocara canis, Toxocara cati

hookworm, threadworm, strongyloidiasis, pinworm, visceral larva migrans, ocular larva migrans, Ancylostoma braziliense, Uncinaria stenocephala, Ancylostoma canium, Ancylostoma ceylanicum, Oesophagostomum bifurcum, Strongyloides fuelleborni, Ternidens diminutus, eosinophilic enteritis, nodular worm infection, swollen belly syndrome, soil-transmitted helminths, STH, urticaria, ascending cholangitis, appendicitis, biliary colic, gastric hemorrhage, granulomatous peritonitis, liver abscess, Meckel diverticulum inflammation, obstructive jaundice, pancreatitis, peritonitis and peritoneal granulomatosis

Contributor Information and Disclosures

Author

William H Shoff, MD, DTM&H, Director, PENN Travel Medicine, Associate Professor, Department of Emergency Medicine, Hospital of the University of Pennsylvania
William H Shoff, MD, DTM&H is a member of the following medical societies: American College of Physicians, American Society of Tropical Medicine and Hygiene, International Society of Travel Medicine, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Glaxo Smith Kline Consulting fee Consulting; Glaxo Smith Kline Honoraria Speaking and teaching

Coauthor(s)

Suzanne Moore Shepherd, MD, MS, DTM&H, FACEP, FAAEM, Associate Professor, Department of Emergency Medicine, Hospital of the University of Pennsylvania; Director of Education and Research, PENN Travel Medicine
Suzanne Moore Shepherd, MD, MS, DTM&H, FACEP, FAAEM is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American Society of Tropical Medicine and Hygiene, International Society of Travel Medicine, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Michael E Greenberg, MD, MPH, Clinical Instructor, Department of Pediatrics, University of California at San Francisco
Michael E Greenberg, MD is a member of the following medical societies: Alpha Omega Alpha, Ambulatory Pediatric Association, American Academy of Pediatrics, and American Public Health Association
Disclosure: Nothing to disclose.

Medical Editor

Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA, Associate Professor in Biomolecular, Biomedical Science & Health, Griffith University; Director of Infectious Diseases and Unit Head of Queensland Paediatric Infectious Laboratory, Sir Albert Sakzewski Viral Research Centre, Royal Children's Hospital
Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Pediatric Infectious Diseases Society, Royal Australasian College of Physicians, and Royal College of Pathologists of Australasia
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Martin Weisse, MD, Program Director, Associate Professor, Department of Pediatrics, West Virginia University
Martin Weisse, MD is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Consulting; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; sanofi pasteur Grant/research funds Unrestricted research grant; sanofi pasteur  Consulting; sanofi pasteur Honoraria Speaking and teaching; Tap Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.